» Articles » PMID: 39456692

Lymphocytes Change Their Phenotype and Function in Systemic Lupus Erythematosus and Lupus Nephritis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Oct 26
PMID 39456692
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease, characterized by considerable changes in peripheral lymphocyte structure and function, that plays a critical role in commencing and reviving the inflammatory and immune signaling pathways. In healthy individuals, B lymphocytes have a major role in guiding and directing defense mechanisms against pathogens. Certain changes in B lymphocyte phenotype, including alterations in surface and endosomal receptors, occur in the presence of SLE and lead to dysregulation of peripheral B lymphocyte subpopulations. Functional changes are characterized by loss of self-tolerance, intra- and extrafollicular activation, and increased cytokine and autoantibody production. T lymphocytes seem to have a supporting, rather than a leading, role in the disease pathogenesis. Substantial aberrations in peripheral T lymphocyte subsets are evident, and include a reduction of cytotoxic, regulatory, and advanced differentiated subtypes, together with an increase of activated and autoreactive forms and abnormalities in follicular T cells. Up-regulated subpopulations, such as central and effector memory T cells, produce pre-inflammatory cytokines, activate B lymphocytes, and stimulate cell signaling pathways. This review explores the pivotal roles of B and T lymphocytes in the pathogenesis of SLE and Lupus Nephritis, emphasizing the multifaceted mechanisms and interactions and their phenotypic and functional dysregulations.

Citing Articles

SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus.

Yang C, Wang X, Zhang Y, Ding N Front Immunol. 2025; 16:1530534.

PMID: 39958362 PMC: 11825474. DOI: 10.3389/fimmu.2025.1530534.

References
1.
Almaani S, Meara A, Rovin B . Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2016; 12(5):825-835. PMC: 5477208. DOI: 10.2215/CJN.05780616. View

2.
Yang J, Li Q, Yang X, Li M . Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice. Mol Med. 2015; 21:364-70. PMC: 4534470. DOI: 10.2119/molmed.2014.00237. View

3.
Michels-van Amelsfort J, Walter G, Taams L . CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev Clin Immunol. 2011; 7(4):499-514. DOI: 10.1586/eci.11.28. View

4.
Yang J, Yang X, Wang L, Li M . B cells control lupus autoimmunity by inhibiting Th17 and promoting Th22 cells. Cell Death Dis. 2020; 11(3):164. PMC: 7054432. DOI: 10.1038/s41419-020-2362-y. View

5.
Nimmerjahn F, Ravetch J . Fc-receptors as regulators of immunity. Adv Immunol. 2007; 96:179-204. DOI: 10.1016/S0065-2776(07)96005-8. View